Global Ligand Binding Assay Market Growth (Status and Outlook) 2023-2029

Global Ligand Binding Assay Market Growth (Status and Outlook) 2023-2029

Ligand binding assays (LBA) are analytical procedures to quantify an analyte (macromolecule) based on its affinity for a ligand, including but not limited to antibodies, antigens, receptors, oligonucleotides and peptides.

LPI (LP Information)' newest research report, the “Ligand Binding Assay Industry Forecast” looks at past sales and reviews total world Ligand Binding Assay sales in 2022, providing a comprehensive analysis by region and market sector of projected Ligand Binding Assay sales for 2023 through 2029. With Ligand Binding Assay sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Ligand Binding Assay industry.

This Insight Report provides a comprehensive analysis of the global Ligand Binding Assay landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Ligand Binding Assay portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Ligand Binding Assay market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Ligand Binding Assay and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Ligand Binding Assay.

The global Ligand Binding Assay market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.

United States market for Ligand Binding Assay is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

China market for Ligand Binding Assay is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Europe market for Ligand Binding Assay is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Global key Ligand Binding Assay players cover Sygnature Discovery, Shanghai Medicilon Inc, Intertek Group plc, PerkinElmer Inc, Charles River, Alliance Pharma, Eurofins Discovery, Creative Biogene and IBR Inc, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.

This report presents a comprehensive overview, market shares, and growth opportunities of Ligand Binding Assay market by product type, application, key players and key regions and countries.

Market Segmentation:

Segmentation by type
Radioactive
Non-radioactive

Segmentation by application
Biomedical Research
Drug Discovery
Others

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Sygnature Discovery
Shanghai Medicilon Inc
Intertek Group plc
PerkinElmer Inc
Charles River
Alliance Pharma
Eurofins Discovery
Creative Biogene
IBR Inc
LGC Limited
Accelero Bioanalytics GmbH
Gifford Bioscience Limited
GE Healthcare
Antigen Discovery Inc

Please note: The report will take approximately 2 business days to prepare and deliver.